Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F. Linzee Mabrey, MD"'
Autor:
F. Linzee Mabrey, MD, Pavan K. Bhatraju, MD, MSc, Eric D. Morrell, MD, Leila R. Zelnick, PhD, Neha A. Sathe, MD, Nicholas G. O’Connor, BS, Carmen Mikacenic, MD, Thomas R. Martin, MD, W. Conrad Liles, MD, PhD, Mark M. Wurfel, MD, PhD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 12, p e0813 (2022)
OBJECTIVES:. To identify and characterize clinical decline after completion of dexamethasone in severe COVID-19 and determine whether interleukin (IL)-6 and other inflammatory biomarkers predict the occurrence of clinical decline. DESIGN:. Prospectiv
Externí odkaz:
https://doaj.org/article/702f096281464ae990290eca015e72e5
Autor:
F. Linzee Mabrey, MD, Leila R. Zelnick, PhD, Eric D. Morrell, MD, Nicholas G. O’Connor, BS, Andrew Hart, BA, Mark M. Wurfel, MD, PhD, W. Conrad Liles, MD, PhD, Pavan K. Bhatraju, MD, MSc
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0754 (2022)
OBJECTIVES:. To determine whether the early serologic response in COVID-19 critical illness is associated with hospital mortality. To evaluate if time-to-seroconversion differs by receipt of dexamethasone therapy. DESIGN:. Patients were prospectively
Externí odkaz:
https://doaj.org/article/045d78be8b9646edaf410f124a463afc
Autor:
F. Linzee Mabrey, MD, Eric D. Morrell, MD, Pavan K. Bhatraju, MD, MSc, Neha A. Sathe, MD, Sana S. Sakr, PhD, Sharon K. Sahi, BS, T. Eoin West, MD, MPH, Carmen Mikacenic, MD, Mark M. Wurfel, MD, PhD
Publikováno v:
Critical Care Explorations, Vol 3, Iss 12, p e0591 (2021)
IMPORTANCE:. In bacterial sepsis, CD14 and its N-terminal fragment (soluble CD14 subtype, “Presepsin”) have been characterized as markers of innate immune responses and emerging evidence has linked both to coronavirus disease 2019 pathophysiology
Externí odkaz:
https://doaj.org/article/851515288e184cbe82f3d9a0e3ba8074